-
【GE CHENG News】China becomes the first country to hold over 4M domestic valid invention patents
2025-05-08China owned 4.015 million domestic valid invention patents by the end of 2023, up 22.4 percent year-on-year, becoming the first country in the world to hold more than 4 million domestic valid invention patents.It took 31 years for the effective number of invention patents in China (excluding Hong Ko -
【GE CHENG News】CAICT: China tops in AI patent applications with a cumulative 1.29 million accounting for 64% of the world's total
2025-05-08Recently, the China Academy of Information and Communications Technology officially released the "White Paper on Global Digital Economy (2023)". According to the white paper, the artificial intelligence industry is ushering in rapid development, with intensifying innovation and application, and the -
【GE CHENG News】Sino Biopharmaceutical successfully applies for the patent of Sirolimus Tablets and achieves its first generic launch
2025-05-08Sino Biopharmaceuticals announced that Sirolimus Tablets (trademark name: Qingweishi) developed by it have received marketing approval from the National Medical Products Administration, which is the first product, since China implemented the early resolution mechanism for drug patent disputes (drug -
【GE CHENG News】Brief report on main statistical data on intellectual property rights in 2023
2025-05-081. PatentIn 2023, the number of authorized invention patents in China was 921,000, the number of authorized utility model patents was 2.09 million, and the number of authorized industrial design patents was 499,100. Among them, there were 4.015 million valid domestic invention patents (excluding Hon -
【Global News】Brazilian Patent and Trademark Office publishes new rule modifying appeal’s proceedings against the rejection of patent applications
2025-05-08On December 12, 2023, the Brazilian Patent and Trademark Office (BPTO) published Opinion No. 1 19/2023, significantly impacting patent applications.Opinion No. 19/2023 establishes that patent applicants are prohibited from introducing amendments during an administrative appeal against the rejection